Literature DB >> 22044706

Characteristics of isolated atrial flutter versus atrial flutter combined with atrial fibrillation.

Michael Peyrol1, Pascal Sbragia, Laurent Bonello, Samuel Lévy, Franck Paganelli.   

Abstract

BACKGROUND: Atrial flutter (AFL) and atrial fibrillation (AF) are "fellow-travellers". AF may be a stable, "isolated" rhythm, a bridge between sinus rhythm and AF, or both arrhythmias can coexist. Whether the characteristics of isolated AFL are different from those of patients with AFL combined with AF is still unclear. AIM: To compare the clinical characteristics of patients with isolated AFL to those of patients with AFL combined with AF, in a series of patients referred for AFL ablation.
METHODS: Seventy-six consecutive patients (mean age 66.9±12.2 years; 53 men) with a history of electrocardiogram-documented paroxysmal or persistent AFL, referred for catheter ablation, underwent clinical work-up including bidimensional echocardiogram. Patients were subdivided into group I (44 with isolated AFL) and group II (32 with AFL and a history of AF).
RESULTS: Underlying heart disease was present in 62 patients (81.6%). Hypertension was the most common cardiac disorder (n=44, 57.9%) and was more prevalent in group II than in group I (75.0% vs 45.5%; P=0.01). Prevalence of prior cardiac surgery was higher in group I (22.7% vs 6.3%; P=0.04). AFL was persistent in 35 group I patients and 17 group II patients (79.5% vs 53.1%; P=0.01). Class I or III antiarrhythmic drug use was more frequent in group II (84.4% vs 45.5%; P=0.001).
CONCLUSION: This study showed significant differences between patients with isolated AFL and those with AFL combined with AF, in the prevalence of underlying heart disease and the use of antiarrhythmic medication, which were higher when both atrial arrhythmias were combined. In turn, the history of cardiac surgery (including atriotomy), was more common in patients with isolated AFL than in those with AFL combined with AF. Copyright Â
© 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22044706     DOI: 10.1016/j.acvd.2011.07.003

Source DB:  PubMed          Journal:  Arch Cardiovasc Dis        ISSN: 1875-2128            Impact factor:   2.340


  5 in total

1.  Incidence of Atrial Fibrillation in African Americans post Atrial Flutter Ablation.

Authors:  Robert L Percell; Robert Helm; Kevin Monahan
Journal:  J Atr Fibrillation       Date:  2020-02-28

Review 2.  Management of Arrhythmias in Heart Failure.

Authors:  Daniele Masarone; Giuseppe Limongelli; Marta Rubino; Fabio Valente; Rossella Vastarella; Ernesto Ammendola; Rita Gravino; Marina Verrengia; Gemma Salerno; Giuseppe Pacileo
Journal:  J Cardiovasc Dev Dis       Date:  2017-02-28

3.  Symptoms and quality of life in patients with coexistent atrial fibrillation and atrial flutter.

Authors:  Samuel Stempfel; Stefanie Aeschbacher; Steffen Blum; Pascal Meyre; Rebecca Gugganig; Jürg H Beer; Richard Kobza; Michael Kühne; Giorgio Moschovitis; Gianluca Menghini; Jan Novak; Stefan Osswald; Nicolas Rodondi; Elisavet Moutzouri; Matthias Schwenkglenks; Fabienne Witassek; David Conen; Christian Sticherling
Journal:  Int J Cardiol Heart Vasc       Date:  2020-06-16

4.  Management of paroxysmal atrial flutter that occurred in an outpatient prior to dental surgery: a case report.

Authors:  Hajime Shimoda; Tetsu Takahashi
Journal:  BMC Oral Health       Date:  2019-12-04       Impact factor: 2.757

5.  Cerebrovascular accidents differ between patients with atrial flutter and patients with atrial fibrillation.

Authors:  Jacek Staszewski; Anna Bilbin-Bukowska; Wojciech Szypowski; Marcin Mejer-Zahorowski; Adam Stępień
Journal:  Arch Med Sci       Date:  2019-07-18       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.